Skip to main content
CNVS
NASDAQ Trade & Services

Cineverse Files S-3 for Resale of 21.8M Shares, Creating Over 100% Potential Dilution

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$2.63
Mkt Cap
$55.203M
52W Low
$1.77
52W High
$7.39
Market data snapshot near publication time

summarizeSummary

Cineverse Corp. filed an S-3 registration statement for the resale of up to 21.8 million shares by selling stockholders, representing over 100% of current outstanding shares and creating a significant market overhang.


check_boxKey Events

  • Massive Potential Dilution

    The S-3 registers 21,805,701 shares for resale, which is over 102% of the 21,294,866 shares currently outstanding, creating a substantial potential for dilution.

  • Selling Stockholder Resale

    The registered shares are for resale by investors who received them through recent convertible note financing and as consideration for the acquisition of IndiCue, Inc.

  • No Direct Company Proceeds from Resale

    Cineverse Corp. will not receive any proceeds from the sale of these 21.8 million shares by the selling stockholders. However, the company could receive up to $13 million from the exercise of associated warrants.

  • Significant Market Overhang

    The registration of such a large volume of shares, valued at approximately $57.7 million (exceeding the company's market cap), creates a considerable overhang on the stock price.


auto_awesomeAnalysis

Cineverse Corp. has filed an S-3 registration statement for the resale of up to 21,805,701 shares of Class A Common Stock by various selling stockholders. This represents a massive potential dilution of over 102% relative to the company's current outstanding shares (21,294,866) and is valued at approximately $57.7 million, exceeding the company's current market capitalization of $55.2 million. The shares are primarily associated with recent convertible note financing (issued February 12, 2026) and the acquisition of IndiCue, Inc. (February 13, 2026). While the company will not receive proceeds from the resale of these shares, it could receive up to $13 million if associated warrants are exercised, which would be used for working capital and acquisitions. This registration creates a significant overhang on the stock, signaling a substantial future supply of shares in the market, particularly concerning given the company's recent Q3 report indicating a net loss, negative working capital, and a debt covenant breach.

At the time of this filing, CNVS was trading at $2.63 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $55.2M. The 52-week trading range was $1.77 to $7.39. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CNVS - Latest Insights

CNVS
Apr 15, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
7
CNVS
Mar 25, 2026, 9:57 PM EDT
Filing Type: 424B3
Importance Score:
9
CNVS
Mar 16, 2026, 9:38 PM EDT
Filing Type: S-3
Importance Score:
9
CNVS
Feb 17, 2026, 9:54 PM EST
Filing Type: 4
Importance Score:
7
CNVS
Feb 17, 2026, 9:54 PM EST
Filing Type: 4
Importance Score:
7
CNVS
Feb 17, 2026, 9:53 PM EST
Filing Type: 4
Importance Score:
8
CNVS
Feb 17, 2026, 9:53 PM EST
Filing Type: 4
Importance Score:
7
CNVS
Feb 17, 2026, 9:52 PM EST
Filing Type: 4
Importance Score:
7
CNVS
Feb 17, 2026, 5:01 PM EST
Filing Type: 10-Q
Importance Score:
8
CNVS
Feb 17, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
8